Orange Book Companion
Biologic Tradenames starting with "A"

Patents whose numbers are in italics have been extended under 35 USC 156. All expiration dates include applicable Sec. 156 and pediatric (PED) extensions.
Products tagged as [GENERIC] have had a generic equivalent approved for at least one strength of the product.


ADLYXIN (SOLUTION) (SUBCUTANEOUS) LIXISENATIDE
Drug Classes: glucagon-like peptide-1 (GLP-1) receptor agonist
NDA Applicant: SANOFI-AVENTIS US      NDA No.: 208471  Prod. No.: 001 RX (0.15MG/3ML (0.05MG/ML)); 002 RX (0.3MG/3ML (0.1MG/ML))
Patents Expiration Patented Use
Pat. No. RE45313 DS* DP* Exendin variant peptides
Claim Types: Compound; Composition
Pat. Sub. Date(s): All strengths: Aug 3, 2016
Jul 12, 2020  
Pat. No. 8475414 DP* Medication delivery device and method for operating a medication delivery device
Claim Types: Device; Method of use
Pat. Sub. Date(s): All strengths: Aug 3, 2016
Dec 28, 2030 U-1881: Improvement in glycemic control in Type 2 diabetes mellitus patients by use of a pen injector
Pat. No. 8882721 DP* Drive assembly suitable for use in a drug delivery device and drug delivery device
Claim Types: Device
Pat. Sub. Date(s): All strengths: Aug 3, 2016
Jun 28, 2031  
Pat. No. 8915888 DP* Dosing and drive mechanism for drug delivery device
Claim Types: Device
Pat. Sub. Date(s): All strengths: Aug 3, 2016
Jun 8, 2030 U-1881: Improvement in glycemic control in Type 2 diabetes mellitus patients by use of a pen injector
Pat. No. 9072836 DP* Drive mechanism for a drug delivery device and drug delivery device
Claim Types: Device
Pat. Sub. Date(s): All strengths: Aug 3, 2016
Mar 15, 2032  
Pat. No. 9084853 DP* Drive mechanism for a drug delivery device and drug delivery device
Claim Types: Device
Pat. Sub. Date(s): All strengths: Aug 3, 2016
Oct 5, 2031  
Pat. No. 9308329 DP* Medication delivery device and method for operating a medication delivery device
Claim Types: Device
Pat. Sub. Date(s): All strengths: Aug 3, 2016
Dec 28, 2030 U-1881: Improvement in glycemic control in Type 2 diabetes mellitus patients by use of a pen injector
Pat. No. 9408893 Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
Claim Types: Method of use
Pat. Sub. Date(s): All strengths: Sep 9, 2016
Aug 27, 2032 U-1894: Combination treatment with a glitazone for improvement of glycemic control in Type 2 diabetes mellitus patients
Pat. No. 9440029 DP* Drive mechanism for a drug delivery device and drug delivery device
Claim Types: Device
Pat. Sub. Date(s): All strengths: Dec 29, 2016
Jan 30, 2032  
Pat. No. 9511193 DP* Assembly and indicator for a drug delivery device
Claim Types: Device
Pat. Sub. Date(s): All strengths: Dec 29, 2016
Jan 19, 2032  
Pat. No. 9707176 DP* Pharmaceutical composition comprising a GLP-1 agonist and methionine
Claim Types: Formulation
Pat. Sub. Date(s): All strengths: Aug 3, 2017
Nov 11, 2030  
Pat. No. 9821032 Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
Claim Types: Method of use
Pat. Sub. Date(s): All strengths: Dec 19, 2017
May 9, 2032 U-2200: Combination treatment with insulin glargine with or without metformin for improvement of glycemic control in Type 2 diabetes mellitus patients
Pat. No. 9855388 DP* Dosing and drive mechanism for drug delivery device
Claim Types: Device; Process; Method of administration
Pat. Sub. Date(s): All strengths: Jan 12, 2018
Apr 24, 2029 U-1881: Improvement in glycemic control in Type 2 diabetes mellitus patients by use of a pen injector
Pat. No. 9981013 Use of AVE0010 for the treatment of diabetes mellitus type 2
Claim Types: Method of use
Pat. Sub. Date(s): All strengths: Jun 8, 2018
Aug 30, 2030 U-2297: Improvement of glycemic control in Type 2 diabetes patients by administering a starting dose of 10 mcg for 14 days and increasing to a maintenance dose of 20 mcg on day 15
Pat. No. 10028910 DP* Pharmaceutical composition comprising a GLP-1-agonist and methionine
Claim Types: Formulation
Pat. Sub. Date(s): All strengths: Jul 30, 2018
Nov 11, 2030  
Pat. No. 10201663 DP* Assembly for a drug delivery device
Claim Types: Part of a dosage form
Pat. Sub. Date(s): All strengths: Jul 9, 2019
Mar 10, 2034  
Exclusivity Expiration Exclusivity Description
Exclusivity Code: NCE - New chemical entity Jul 27, 2021  

ADMELOG (SOLUTION) (INTRAVENOUS, SUBCUTANEOUS) INSULIN LISPRO
Drug Classes: insulin analog
NDA Applicant: SANOFI-AVENTIS US      NDA No.: 209196  Prod. No.: 001 RX (1000 UNITS/10ML (100 UNITS/ML))
Exclusivity Expiration Exclusivity Description
Exclusivity Code: NP - New product Dec 11, 2020  

ADMELOG SOLOSTAR (SOLUTION) (INTRAVENOUS, SUBCUTANEOUS) INSULIN LISPRO
Drug Classes: insulin analog
NDA Applicant: SANOFI-AVENTIS US      NDA No.: 209196  Prod. No.: 002 RX (300 UNITS/3ML (100 UNITS/ML))
Patents Expiration Patented Use
Pat. No. 7918833 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Sep 23, 2027  
Pat. No. 8512297 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Sep 15, 2024  
Pat. No. 8556864 DP* Drive mechanisms suitable for use in drug delivery devices
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Mar 3, 2024  
Pat. No. 8603044 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Mar 2, 2024  
Pat. No. 8679069 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Apr 12, 2025  
Pat. No. 8992486 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Jun 5, 2024  
Pat. No. 9011391 DP* Pen-type injector
Claim Types: Method of use
Pat. Sub. Date(s): 002: Mar 30, 2018
Mar 26, 2024 U-1832: Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a threaded drive sleeve
Pat. No. 9233211 DP* Relating to a pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Mar 2, 2024  
Pat. No. 9408979 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Mar 2, 2024  
Pat. No. 9526844 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Mar 2, 2024  
Pat. No. 9533105 DP* Drive mechanisms suitable for use in drug delivery devices
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Aug 17, 2024  
Pat. No. 9561331 DP* Drive mechanisms suitable for use in drug delivery devices
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Aug 28, 2024  
Pat. No. 9604008 DP* Drive mechanisms suitable for use in drug delivery devices
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Mar 2, 2024  
Pat. No. 9604009 DP* Drive mechanisms suitable for use in drug delivery devices
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Aug 16, 2024  
Pat. No. 9610409 DP* Drive mechanisms suitable for use in drug delivery devices
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Mar 2, 2024  
Pat. No. 9623189 DP* Relating to drive mechanisms suitable for use in drug delivery devices
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Aug 19, 2024  
Pat. No. 9717852 DP* Cartridge holder and pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 002: Jul 11, 2018
Apr 8, 2033  
Pat. No. 9775954 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 002: Mar 30, 2018
Mar 2, 2024  
Pat. No. 9827379 DP* Drive mechanisms suitable for use in drug delivery devices
Claim Types: Device; Method of administration
Pat. Sub. Date(s): 002: Mar 30, 2018
Mar 4, 2024 U-2146: Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a rotating drive sleeve
Exclusivity Expiration Exclusivity Description
Exclusivity Code: NP - New product Dec 11, 2020  

AFREZZA (POWDER) (INHALATION) INSULIN RECOMBINANT HUMAN
Drug Classes: insulin analog
NDA Applicant: MANNKIND      NDA No.: 022472  Prod. No.: 001 RX (4 UNITS/INH); 002 RX (8 UNITS/INH); 003 RX (12 UNITS/INH)
Patents Expiration Patented Use
Pat. No. 6444226 DP* Purification and stabilization of peptide and protein pharmaceutical agents
Claim Types: Formulation; Method of use; Process
Pat. Sub. Date(s): All strengths: Jul 24, 2014
Jun 29, 2020 U-1534: Administration of a composition comprising insulin complexed with a diketopiperazine.
Pat. No. 6652885 Purification and stabilization of peptide and protein pharmaceutical agents
Claim Types: Method of use
Pat. Sub. Date(s): All strengths: Jul 24, 2014
Jun 29, 2020 U-1535: Administration of a composition comprising insulin complexed with microparticles of a diketopiperazine.
Pat. No. 7305986 DP* Unit dose capsules for use in a dry powder inhaler
Claim Types: Device
Pat. Sub. Date(s): 001: Jul 24, 2014; 002: Jul 24, 2014; 003: May 15, 2015
Jan 16, 2023  
Pat. No. 7464706 DP* Unit dose cartridge and dry powder inhaler
Claim Types: Device; Method of administration
Pat. Sub. Date(s): 001: Jul 24, 2014; 002: Jul 24, 2014; 003: May 15, 2015
Mar 2, 2023  
Pat. No. 7648960 Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles
Claim Types: Method of use
Pat. Sub. Date(s): All strengths: Jul 24, 2014
Jun 29, 2020 U-1535: Administration of a composition comprising insulin complexed with microparticles of a diketopiperazine.
Pat. No. 7943178 DP* Methods and compositions for delivering peptides
Claim Types: Method of use; Product-by-process
Pat. Sub. Date(s): All strengths: Jul 24, 2014
Jun 29, 2020 U-1535: Administration of a composition comprising insulin complexed with microparticles of a diketopiperazine.
Pat. No. 7943572 Superior control of blood glucose in diabetes treatment
Claim Types: Method of administration
Pat. Sub. Date(s): All strengths: Jul 24, 2014
Aug 10, 2026 U-1539: Pulmonary administration of an insulin composition comprising FDKP at the beginning of a meal to a patient also being treated with a long-acting insulin.
Pat. No. 8119593 Method of treating diabetes type 2 by metformin and an ultrarapid acting insulin
Claim Types: Method of administration
Pat. Sub. Date(s): All strengths: Jul 24, 2014
Aug 11, 2029 U-1537: Treatment of a patient having diabetes mellitus with a prandial rapid acting insulin.
Pat. No. 8146588 DP* Unit dose capsules and dry powder inhaler
Claim Types: Device
Pat. Sub. Date(s): 001: Jul 24, 2014; 002: Jul 24, 2014; 003: May 15, 2015
Apr 24, 2023  
Pat. No. 8156936 DP* Unit dose capsules and dry powder inhaler
Claim Types: Device
Pat. Sub. Date(s): 001: Jul 24, 2014; 002: Jul 24, 2014; 003: May 15, 2015
Jan 16, 2023  
Pat. No. 8215300 DP* Unit dose cartridge and dry powder inhaler
Claim Types: Device
Pat. Sub. Date(s): 001: Jul 24, 2014; 002: Jul 24, 2014; 003: May 15, 2015
Nov 24, 2022  
Pat. No. 8258095 Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content
Claim Types: Method of administration
Pat. Sub. Date(s): All strengths: Jul 24, 2014
Aug 11, 2029 U-1537: Treatment of a patient having diabetes mellitus with a prandial rapid acting insulin.
Pat. No. 8389470 DP* Methods and compositions for delivering peptides
Claim Types: Method of use; Formulation
Pat. Sub. Date(s): All strengths: Jul 24, 2014
Jun 29, 2020 U-1621: Pulmonary administration of a composition comprising insulin bound to a complexing agent.
Pat. No. 8424518 DP* Dry powder inhaler and system for drug delivery
Claim Types: Device
Pat. Sub. Date(s): 001: Jul 24, 2014; 002: Jul 24, 2014; 003: May 15, 2015
Oct 17, 2031  
Pat. No. 8485180 DP* Dry powder drug delivery system
Claim Types: Device
Pat. Sub. Date(s): 001: Jul 24, 2014; 002: Jul 24, 2014; 003: May 15, 2015
Mar 25, 2030  
Pat. No. 8499757 DP* Dry powder inhaler and system for drug delivery
Claim Types: Device
Pat. Sub. Date(s): 001: Jul 24, 2014; 002: Jul 24, 2014; 003: May 15, 2015
Feb 19, 2032  
Pat. No. 8551528 DP* Diketopiperazine microparticles with defined specific surface areas
Claim Types: Formulation
Pat. Sub. Date(s): 001: Jul 24, 2014; 002: Jul 24, 2014; 003: May 15, 2015
Jun 11, 2030  
Pat. No. 8623817 Method of treating diabetes type 2 by administering ultrarapid acting insulin
Claim Types: Method of use
Pat. Sub. Date(s): All strengths: Jul 24, 2014
Sep 18, 2029 U-1537: Treatment of a patient having diabetes mellitus with a prandial rapid acting insulin.
Pat. No. 8636001 DP* Dry powder inhaler and system for drug delivery
Claim Types: Device
Pat. Sub. Date(s): 001: Jul 24, 2014; 002: Jul 24, 2014; 003: May 15, 2015
Jul 12, 2032  
Pat. No. 8729019 DP* Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
Claim Types: Formulation
Pat. Sub. Date(s): 001: Jul 24, 2014; 002: Jul 14, 2014; 003: May 15, 2015
Dec 26, 2028  
Pat. No. 8734845 DP* Diketopiperazine microparticles with defined specific surface areas
Claim Types: Formulation
Pat. Sub. Date(s): 001: Jul 24, 2014; 002: Jul 24, 2014; 003: May 15, 2015
Jun 11, 2030  
Pat. No. 8778403 DP* Diketopiperazine microparticles with defined specific surface areas
Claim Types: Device; Method of administration
Pat. Sub. Date(s): All strengths: Jul 24, 2014
Jun 11, 2030 U-1538: Administration of FDKP microparticles comprising insulin.
Pat. No. 8889099 DP* Methods and compositions for delivering peptides
Claim Types: Method of administration; Formulation
Pat. Sub. Date(s): All strengths: Dec 17, 2014
Jun 29, 2020 U-1621: Pulmonary administration of a composition comprising insulin bound to a complexing agent.
Pat. No. 8912193 DP* Dry powder inhaler and system for drug delivery
Claim Types: Composition; Method of use; Product-by-process; Method of administration
Pat. Sub. Date(s): All strengths: Aug 18, 2015
Jun 12, 2029 U-1538: Administration of FDKP microparticles comprising insulin.
Pat. No. 8950397 DP* Unit dose cartridge and dry powder inhaler
Claim Types: Device
Pat. Sub. Date(s): All strengths: Apr 25, 2016
Jul 20, 2021  
Pat. No. 9192675 DP* Dry powder inhaler and system for drug delivery
Claim Types: Device; Drug in a container
Pat. Sub. Date(s): All strengths: Dec 23, 2015
Jun 12, 2029 U-1788: Treatment of patient having diabetes mellitus via oral inhalation of fdkp microparticles comprising insulin
Pat. No. 9283193 DP* Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
Claim Types: Formulation
Pat. Sub. Date(s): All strengths: Apr 12, 2016
Sep 14, 2026  
Pat. No. 9339615 DP* Dry powder inhaler and system for drug delivery
Claim Types: Device
Pat. Sub. Date(s): All strengths: May 31, 2016
Oct 20, 2029  
Pat. No. 9358352 DP* Dry powder drug delivery system and methods
Claim Types: Device; Drug in a container; Method of administration
Pat. Sub. Date(s): All strengths: Jun 30, 2016
Feb 15, 2031 U-1861: Use of an inhaler to administer dry powder medicament
Pat. No. 9393372 DP* Dry powder drug delivery system
Claim Types: Device
Pat. Sub. Date(s): All strengths: Aug 3, 2016
Jul 4, 2029  
Pat. No. 9446133 DP* Dry powder inhaler and system for drug delivery
Claim Types: Composition; Formulation; Method of use; Method of administration
Pat. Sub. Date(s): All strengths: Oct 19, 2016
Jun 12, 2029 U-1861: Use of an inhaler to administer dry powder medicament
Pat. No. 9511198 Dry powder inhaler and system for drug delivery
Claim Types: Method of use
Pat. Sub. Date(s): All strengths: Jan 5, 2017
Feb 16, 2030 U-1929: Treatment of diabetes mellitus with an inhaled insulin to improve glycemic control using a dry powder inhalation system comprising an inhaler, a cartridge and a dry powder medicament comprising insulin in a single inhalation
U-1930: Method of aerosolizing/deagglomerating an insulin dry powder for use in treating diabetes mellitus via oral inhalation using an inhaler with a cartridge containing the insulin dry powder.
Pat. No. 9597374 Use of ultrarapid acting insulin
Claim Types: Method of use
Pat. Sub. Date(s): All strengths: Apr 11, 2017
Oct 8, 2031 U-1987: Method of controlling glycemia in diabetics by administering an initial dose of insulin-FDKP with a meal; determining blood glucose level 1-2 hrs after and administering a supplemental dose of insulin-FDKP if postprandial glucose level is >140 mg/dl
Pat. No. 9662461 DP* Dry powder drug delivery system and methods
Claim Types: Device; Method of administration
Pat. Sub. Date(s): All strengths: Jun 26, 2017
Jun 12, 2029 U-2019: Method of delivering to a patient with diabetes mellitus in a single inhalation, greater than 75% of a dry powder dose comprising insulin and fumaryl diketopiperazine using a high resistance to flow dry powder inhaler.
Pat. No. 9717689 DP* Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
Claim Types: Formulation
Pat. Sub. Date(s): All strengths: Aug 28, 2017
Sep 14, 2026  
Pat. No. 9943571 Use of ultrarapid acting insulin
Claim Types: Method of use
Pat. Sub. Date(s): All strengths: May 15, 2018
Aug 11, 2029 U-1537: Treatment of a patient having diabetes mellitus with a prandial rapid acting insulin.
Pat. No. 10046031 Use of ultrarapid acting insulin
Claim Types: Method of use
Pat. Sub. Date(s): All strengths: Sep 12, 2018
Aug 11, 2029 U-2383: Method of controlling glycemia in a diabetic patient with delayed or prolonged food absorpbtion by administering 50 to 75% of a predetermined dose of insulin-FDKP at mealtime, and administering remainder of dose 30-120 minutes after beginning of meal
Pat. No. 10201672 DP* Dry powder inhaler and system for drug delivery
Claim Types: Device
Pat. Sub. Date(s): All strengths: Mar 4, 2019
Aug 2, 2030  
Pat. No. 10342938 DP* Dry powder drug delivery system
Claim Types: Device
Pat. Sub. Date(s): All strengths: Jul 23, 2019
Jun 12, 2029  
Pat. No. 10500159 DP* Apparatus and method for cryogranulating a pharmaceutical composition
Claim Types: Product-by-process
Pat. Sub. Date(s): All strengths: Dec 19, 2019
Nov 2, 2030  

APIDRA (INJECTABLE) (INTRAVENOUS, SUBCUTANEOUS) INSULIN GLULISINE RECOMBINANT
Drug Classes: insulin analog
NDA Applicant: SANOFI AVENTIS US      NDA No.: 021629  Prod. No.: 001 RX (1000 UNITS/10ML (100 UNITS/ML)) NDA No.: 021629  Prod. No.: 002 DISC (300 UNITS/3ML (100 UNITS/ML))
Patents Expiration Patented Use
Pat. No. 6960561 DP* Zinc-free and low-zinc insulin preparations having improved stability
Claim Types: Formulation; Process
Pat. Sub. Date(s): All strengths: None
Jan 25, 2023 U-471: Method of treating a patient suffering from diabetes mellitus
Pat. No. 7452860 DP* Zinc-free and low-zinc insulin preparations having improved stability
Claim Types: Formulation
Pat. Sub. Date(s): All strengths: None
Mar 22, 2022  
Pat. No. 7696162 DP* Zinc-free and low-zinc insulin preparations having improved stability
Claim Types: Formulation; Method of use
Pat. Sub. Date(s): All strengths: None
Mar 22, 2022 U-471: Method of treating a patient suffering from diabetes mellitus

APIDRA SOLOSTAR (INJECTABLE) (SUBCUTANEOUS) INSULIN GLULISINE RECOMBINANT
Drug Classes: insulin analog
NDA Applicant: SANOFI AVENTIS US      NDA No.: 021629  Prod. No.: 003 RX (300 UNITS/3ML)
Patents Expiration Patented Use
Pat. No. 6960561 DP* Zinc-free and low-zinc insulin preparations having improved stability
Claim Types: Formulation; Process
Pat. Sub. Date(s): 003: None
Jan 25, 2023 U-471: Method of treating a patient suffering from diabetes mellitus
Pat. No. 7452860 DP* Zinc-free and low-zinc insulin preparations having improved stability
Claim Types: Formulation
Pat. Sub. Date(s): 003: None
Mar 22, 2022  
Pat. No. 7696162 DP* Zinc-free and low-zinc insulin preparations having improved stability
Claim Types: Formulation; Method of use
Pat. Sub. Date(s): 003: None
Mar 22, 2022 U-471: Method of treating a patient suffering from diabetes mellitus
Pat. No. 7918833 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 003: None
Sep 23, 2027  
Pat. No. 8512297 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 003: Aug 21, 2013
Sep 15, 2024  
Pat. No. 8556864 DP* Drive mechanisms suitable for use in drug delivery devices
Claim Types: Device
Pat. Sub. Date(s): 003: Nov 6, 2013
Mar 3, 2024  
Pat. No. 8603044 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 003: Jan 6, 2014
Mar 2, 2024  
Pat. No. 8679069 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 003: Mar 25, 2014
Apr 12, 2025  
Pat. No. 8992486 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 003: Apr 9, 2015
Jun 5, 2024  
Pat. No. 9011391 Pen-type injector
Claim Types: Method of use
Pat. Sub. Date(s): 003: May 1, 2015
Mar 26, 2024 U-1832: Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a threaded drive sleeve
Pat. No. 9233211 DP* Relating to a pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 003: Jan 13, 2016
Mar 2, 2024  
Pat. No. 9408979 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 003: Sep 15, 2016
Mar 2, 2024  
Pat. No. 9526844 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 003: Dec 27, 2016
Mar 2, 2024  
Pat. No. 9533105 DP* Drive mechanisms suitable for use in drug delivery devices
Claim Types: Device
Pat. Sub. Date(s): 003: Jan 3, 2017
Aug 17, 2024  
Pat. No. 9561331 DP* Drive mechanisms suitable for use in drug delivery devices
Claim Types: Device
Pat. Sub. Date(s): 003: Feb 7, 2017
Aug 28, 2024  
Pat. No. 9604008 DP* Drive mechanisms suitable for use in drug delivery devices
Claim Types: Device
Pat. Sub. Date(s): 003: Mar 28, 2017
Mar 2, 2024  
Pat. No. 9604009 DP* Drive mechanisms suitable for use in drug delivery devices
Claim Types: Device
Pat. Sub. Date(s): 003: Mar 28, 2017
Aug 16, 2024  
Pat. No. 9610409 DP* Drive mechanisms suitable for use in drug delivery devices
Claim Types: Device
Pat. Sub. Date(s): 003: Apr 4, 2017
Mar 2, 2024  
Pat. No. 9623189 DP* Relating to drive mechanisms suitable for use in drug delivery devices
Claim Types: Device
Pat. Sub. Date(s): 003: Apr 18, 2017
Aug 19, 2024  
Pat. No. 9717852 DP* Cartridge holder and pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 003: Jul 11, 2018
Apr 8, 2033  
Pat. No. 9775954 DP* Pen-type injector
Claim Types: Device
Pat. Sub. Date(s): 003: Oct 3, 2017
Mar 2, 2024  
Pat. No. 9827379 DP* Drive mechanisms suitable for use in drug delivery devices
Claim Types: Device; Method of administration
Pat. Sub. Date(s): 003: Nov 28, 2017
Mar 2, 2024 U-2146: Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a rotating drive sleeve


DS*=Drug Substance and DP*=Drug Product: patent submitted for the product after Aug. 18, 2003.
Last edited: 18 April 2020
2001-2020 Bruce A. Pokras, All rights reserved worldwide